Will Moderna Stock Recover?
The global impacts of COVID-19 are finally easing. But in spite of the damage the pandemic inflicted on the economy at large, some companies directly benefited …
The global impacts of COVID-19 are finally easing. But in spite of the damage the pandemic inflicted on the economy at large, some companies directly benefited …
Uncovering the right stocks to channel your hard-earned resources into can be an exciting and daunting challenge. However, if you have $50,000 to hand, you …
Moderna (MRNA) stock experienced exponential growth over the past few years due to profits and publicity from its coronavirus vaccine. As the demand for …
CureVac is a German biotechnology company that specializes in the development of messenger RNA (mRNA) vaccines and therapies. CureVac has been focused on using …
Moderna (NASDAQ:MRNA) rocketed to prominence at the height of the COVID-19 pandemic as an early developer of a vaccine against the coronavirus. Since …
What Stocks To Buy If Nuclear War Breaks Out? The specter of nuclear war is once more a reality for humankind, only this time, the potential catalyst happens …
Moderna vs Teladoc Stock: The booming pre-COVID economy is gone, and a growing number of experts suggest that a recession is inevitable. However, despite this …
Pfizer vs Moderna Legal Battle: American biotechnology firm Moderna emerged as one of the most widely-recognized success stories of the coronavirus era. The …
In the investment world, it seems that the slow and steady approach always wins the race. Indeed, a reliable business with a rock-solid dividend is practically …
Philippe Laffont Block: Technology is advancing at such a rapid rate that established businesses can barely keep up. The startups launched by entrepreneurs and …
March 2020. Worldwide stay-at-home orders. The worst public health crisis since 1918’s Spanish Flu outbreak. Though the world was on lockdown, it didn’t …
The biotech sector suffered a mixed run of fortunes lately. While some industry stalwarts, like Pfizer, Stryker, and Roche, are down double digits this year, …
Biotech firms can be a risky bet at the best of times, but when they do pay off they deliver the goods in a way that few other businesses can match. Take …